In early 2019, Jennifer Hepworth and her husband were stunned by a large bill they unexpectedly received for their daughter’s prescription cystic fibrosis medication. Their payment had risen to $3,500 ...

Matt Turner, President of Patient Affordability, Paysign discusses the evolving financial threats to pharmaceutical ...

CINCINNATI, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”), a biotechnology and pharmaceutical company spanning multiple sectors, today announced the ...

Matthew Turner, President of Patient Affordability, Paysign discusses how next-generation copay assistance appears to be less about consolidating services under one vendor and more about assembling ...

Please provide your email address to receive an email when new articles are posted on . A recent legal battle over copay assistance programs for biologic medications, and whether they must count ...

Copay maximizers allow plans to “maximize” the value extracted from copay assistance programs by adjusting a patient’s cost-sharing to the maximum amount of available assistance and not allowing the ...

60% of patients say they couldn’t afford their meds without copay assistance Nearly half of patients and caregivers say they or someone in their immediate household has not been able to afford their ...

Add Yahoo as a preferred source to see more of our stories on Google. Ohio lawmakers have a chance to protect patients from harmful and discriminatory insurance practices by passing Senate Bill 207, a ...

Two key pillars of the Affordable Care Act (ACA) are its creation of essential health benefits (EHBs) and its imposition of annual limits on cost sharing. The ACA’s annual limits on cost sharing were ...

Over the course of 2025, Jayant Mishra of Mission Viejo, California, progressively developed scaly, itchy red patches on his skin. Then came the pain and swelling in the joints of his hands, making it ...

Change is unlikely to come soon. Insurers and employers have long complained that copay assistance programs are mainly a marketing ploy by the drug industry that encourages patients to stay on costly ...

Kelly Chellis is Ohio Volunteer Advocacy Committee chair of the Arthritis Foundation of Ohio. Ohio lawmakers have a chance to protect patients from harmful and discriminatory insurance practices by ...